The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wesche Holger since 2020.
This trader's CIK number is 1763592.
At the time of last reporting, Wesche Holger was the Chief Scientific Officer of Harpoon Therapeutics, Inc.. (stock ticker symbol HARP).
Also see all insider trading activities at Harpoon Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | HARP | 0 | $0 | 30,000 | $531,130 | 30,000 | $18,000 |
| 2020 | HARP | 0 | $0 | 40,000 | $613,004 | 40,000 | $24,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-07-01 | HARP | Option Ex | 10,000 | .60 | 6,000 |
| 2021-07-01 | HARP | Sale | 10,000 | 14.00 | 140,000 |
| 2021-04-01 | HARP | Option Ex | 10,000 | .60 | 6,000 |
| 2021-04-01 | HARP | Sale | 10,000 | 20.78 | 207,760 |
| 2021-01-04 | HARP | Sale | 10,000 | 18.34 | 183,370 |
| 2021-01-04 | HARP | Option Ex | 10,000 | .60 | 6,000 |
| 2020-10-01 | HARP | Sale | 10,000 | 16.61 | 166,100 |
| 2020-10-01 | HARP | Option Ex | 10,000 | .60 | 6,000 |
| 2020-07-01 | HARP | Option Ex | 10,000 | .60 | 6,000 |
| 2020-07-01 | HARP | Sale | 10,000 | 16.20 | 161,990 |
| 2020-05-12 | HARP | Option Ex | 1,400 | .60 | 840 |
| 2020-05-12 | HARP | Sale | 1,400 | 14.09 | 19,720 |
| 2020-05-11 | HARP | Sale | 1,000 | 14.06 | 14,065 |
| 2020-05-11 | HARP | Option Ex | 1,000 | .60 | 600 |
| 2020-05-08 | HARP | Sale | 1,000 | 14.00 | 14,000 |
| 2020-05-07 | HARP | Sale | 5,350 | 14.13 | 75,574 |
| 2020-05-08 | HARP | Option Ex | 1,000 | .60 | 600 |
| 2020-05-07 | HARP | Option Ex | 5,350 | .60 | 3,210 |
| 2020-04-28 | HARP | Sale | 1,250 | 14.05 | 17,565 |
| 2020-04-28 | HARP | Option Ex | 1,250 | .60 | 750 |
| 2020-01-02 | HARP | Sale | 10,000 | 14.40 | 143,990 |
| 2020-01-02 | HARP | Option Ex | 10,000 | .60 | 6,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wesche Holger (Chief Scientific Officer of Harpoon Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.